Q2 2026 · Form 13F LedgerData source: SEC EDGAR  
H

HOLDER.TOP

Who owns what — the quarterly ledger of U.S. institutional holdings.
EN · 简 · 繁
Funds / Sio Capital Management, LLC
Form 13F · Q2 2026

Sio Capital Management, LLC

CIK 1482416Filed 2026-08-1413F-HR View the filing on EDGAR ↗
$604M
Reported book value
59
Positions
12
Quarters on record
Top 50
Positions

Sio Capital Management, LLC — holdings

Top 50 positions of 59, ranked by reported value. Share change is versus the previous quarter.
#SecuritySharesShare Δ QoQValue% of book
1AVR Anteris Technologies Global5.5M+3.0%$55M9.0%
2COR Cencora Inc173,588+72.0%$49M8.1%
3MMS Maximus Inc715,267−7.0%$38M6.4%
4ALLO Allogene Therapeutics Inc13.3M—$28M4.6%
5GMED Globus Med Inc301,816—$24M3.9%
6GSK Gsk Plc436,700+13.2%$23M3.8%
7TYRA Tyra Biosciences Inc695,315+14.8%$22M3.7%
8WAY Waystar Hldg Corp925,834−43.6%$19M3.1%
9IDYA Ideaya Biosciences Inc480,383—$18M3.0%
10ORKA Oruka Therapeutics Inc177,118+33.7%$17M2.8%
11CI The Cigna Group57,750—$16M2.6%
12SNY Sanofi Sa364,200+52.0%$16M2.6%
13ICLR Icon Pub Ltd Co88,186−71.2%$15M2.5%
14VTRS Viatris Inc954,299—$15M2.5%
15CROSS CTRY HEALTHCARE INC Cross Ctry Healthcare Inc1.1M+0.0%$15M2.4%
16RAPP Rapport Therapeutics Inc307,657−16.1%$13M2.1%
17ABT Abbott Laboratories128,656−31.0%$12M1.9%
18CELC Celcuity Inc110,022−43.2%$12M1.9%
19ZBH Zimmer Biomet Holdings Inc131,445+109.9%$11M1.9%
20REGN Regeneron Pharmaceuticals18,000—$11M1.9%
21BMY Bristol-Myers Squibb Co193,500—$11M1.8%
22MDT Medtronic Plc142,500—$11M1.8%
23VIR Vir Biotechnology Inc1.1M−28.2%$11M1.8%
24SENS Senseonics Hldgs Inc1.6M+1275.6%$9M1.5%
25EYPT Eyepoint Inc623,130−13.7%$9M1.5%
26CYBIN INC Cybin Inc1.3M—$9M1.4%
27ANIP Ani Pharmaceuticals Inc97,305−63.4%$8M1.3%
28TARA Protara Therapeutics Inc1.9M−2.4%$7M1.2%
29RLMD Relmada Therapeutics Inc1.0M+4.0%$7M1.1%
30TNGX Tango Therapeutics Inc208,500—$7M1.1%
31AQST Aquestive Therapeutics Inc1.5M−22.7%$6M1.0%
32DNTH Dianthus Therapeutics Inc59,254−84.0%$6M1.0%
33SION Sionna Therapeutics Inc127,808−56.6%$6M0.9%
34OCUL Ocular Therapeutix Inc539,493−44.3%$5M0.9%
35ZBIO Zenas Biopharma Inc208,557−37.1%$5M0.9%
36DRUG Bright Minds Biosciences Inc73,952−14.1%$5M0.9%
37OKUR Onkure Therapeutics Inc1.1M+0.0%$5M0.8%
38SVRA Savara Inc617,675+0.6%$4M0.6%
39PMVP Pmv Pharmaceuticals Inc2.6M−14.4%$4M0.6%
40AVAH Aveanna Healthcare Hldgs Inc369,036—$3M0.5%
41OVID Ovid Therapeutics Inc1.0M−19.7%$3M0.4%
42IMNM Immunome Inc124,168−24.8%$3M0.4%
43ANTX An2 Therapeutics Inc529,933−19.4%$3M0.4%
44SER Serina Therapeutics Inc1.0M+0.0%$2M0.3%
45ALGS Aligos Therapeutics Inc327,237+0.0%$2M0.3%
46IBIO Ibio Inc904,268+0.0%$2M0.3%
47XLO Xilio Therapeutics Inc152,464+0.0%$1M0.2%
48AORT Artivion Inc48,481—$1M0.2%
49BBOT Bridgebio Oncology Therapeut130,628+0.0%$995,3850.2%
50TELA Tela Bio Inc636,300+0.0%$477,2250.1%
Source: Form 13F filings via SEC EDGAR. Positions as of Jun 30, 2026. Options (put/call) are excluded from share counts.